Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROSG

(ROSG) (ROSG) Stock Price, News & Analysis

(ROSG) logo

About (ROSG) Stock (NASDAQ:ROSG)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.44
50-Day Range
$0.43
$0.43
52-Week Range
$0.23
$2.75
Volume
169,599 shs
Average Volume
81,512 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

Receive ROSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter.

ROSG Stock News Headlines

Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Rosetta Genomics Ltd ROSGQ
See More Headlines

ROSG Stock Analysis - Frequently Asked Questions

(ROSG) (NASDAQ:ROSG) posted its earnings results on Thursday, May, 19th. The medical research company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The medical research company had revenue of $2.60 million for the quarter, compared to analysts' expectations of $3.36 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROSG) investors own include Agenus (AGEN), Bausch Health Companies (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and (SCMP) (SCMP).

Company Calendar

Last Earnings
5/19/2016
Today
4/25/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ROSG
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:ROSG) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners